PARK
Park Dental Partners, Inc.
NASDAQ · Healthcare · Medical - Equipment & Services · US
$20.06
−2.79%Year over year
Reported trailing growth
- Revenue
- +7.3%
- EBITDA
- -86.9%
- EBIT
- +12.5%
- EPS
- —
- Free cash flow
- —
- Operating cash flow
- —
Forward estimates
Based on analyst estimates
- Revenue
- +14.7%
- EBITDA
- +864.1%
- EPS
- +271.9%
Three-year CAGR
- Revenue
- +4.6%
- EBITDA
- +8.0%
- EBIT
- +14.0%
- Net income
- —
- EPS
- —
- Free cash flow
- +64.0%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026